MedTrace Logo

Characterization of the Prosocial and Prosexual Effects of GHB

NCT02342366 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2019-07-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether gamma-Hydroxybutyrate (GHB) has prosocial and prosexual effects in healthy male participants, and to characterize these putative effects via behavioral tests, functional magnetic resonance imaging (fMRI), electroencephalography (EEG), and neuroendocrine parameters. The investigators predict that GHB in fact has prosocial and prosexual effects which can be neurobiologically characterized using the assessed methods. Such effects would be of high interest for the treatment of mental disorders which involve impairments of social interaction and sexual function such as major depression or autism.

Conditions

Interventions

DRUG

GHB 35 mg/kg p.o.

GHB 35 mg/kg p.o.

DRUG

GHB 20 mg/kg p.o.

GHB 20 mg/kg p.o.

Sponsors & Collaborators

  • University of Regensburg

    collaborator OTHER

  • University of Salerno

    collaborator OTHER

  • University of Vienna

    collaborator OTHER

  • University of Freiburg

    collaborator OTHER

  • University of Zurich

    lead OTHER

Principal Investigators

  • Erich Seifritz, Professor · University of Zurich

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2014-11-30
Completion
2014-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02342366 on ClinicalTrials.gov